New pill trial targets Tough-to-Treat blood cancer comeback
NCT ID NCT06311227
Summary
This study is testing whether a pill called venetoclax can help control hairy cell leukemia that has come back after previous treatments. About 20 adults whose cancer has relapsed will take the daily pill for up to 19 months. Researchers want to see if the treatment shrinks the cancer, puts it into remission, and is safe for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT HAIRY CELL LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Comprehensive Cancer Center
RECRUITINGDuarte, California, 91010, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
City of Hope at Irvine Lennar
RECRUITINGIrvine, California, 92618, United States
Contact
Contact Phone: •••-•••-••••
-
NCI - Center for Cancer Research
RECRUITINGBethesda, Maryland, 20892, United States
Contact
Contact Phone: •••-•••-••••
-
Ohio State University Comprehensive Cancer Center
SUSPENDEDColumbus, Ohio, 43210, United States
-
UM Sylvester Comprehensive Cancer Center at Aventura
RECRUITINGAventura, Florida, 33180, United States
Contact
Contact Phone: •••-•••-••••
-
UM Sylvester Comprehensive Cancer Center at Coral Gables
RECRUITINGCoral Gables, Florida, 33146, United States
Contact
Contact Phone: •••-•••-••••
-
UM Sylvester Comprehensive Cancer Center at Coral Springs
RECRUITINGCoral Springs, Florida, 33065, United States
Contact
Contact Phone: •••-•••-••••
-
UM Sylvester Comprehensive Cancer Center at Deerfield Beach
RECRUITINGDeerfield Beach, Florida, 33442, United States
Contact
Contact Phone: •••-•••-••••
-
UM Sylvester Comprehensive Cancer Center at Doral
RECRUITINGDoral, Florida, 33166, United States
Contact
Contact Email: •••••@•••••
-
UM Sylvester Comprehensive Cancer Center at Hollywood
RECRUITINGHollywood, Florida, 33021, United States
Contact
Contact Phone: •••-•••-••••
-
UM Sylvester Comprehensive Cancer Center at Kendall
RECRUITINGMiami, Florida, 33176, United States
Contact
Contact Phone: •••-•••-••••
-
University of Cincinnati Cancer Center-UC Medical Center
SUSPENDEDCincinnati, Ohio, 45219, United States
-
University of Cincinnati Cancer Center-West Chester
SUSPENDEDWest Chester, Ohio, 45069, United States
-
University of Kansas Cancer Center
RECRUITINGKansas City, Kansas, 66160, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Kansas Cancer Center - Briarcliff
RECRUITINGKansas City, Missouri, 64116, United States
Contact
Contact Phone: •••-•••-••••
-
University of Kansas Cancer Center - Lee's Summit
RECRUITINGLee's Summit, Missouri, 64064, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Kansas Cancer Center - North
RECRUITINGKansas City, Missouri, 64154, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Kansas Cancer Center-Overland Park
RECRUITINGOverland Park, Kansas, 66210, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Kansas Hospital-Westwood Cancer Center
RECRUITINGWestwood, Kansas, 66205, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Maryland/Greenebaum Cancer Center
SUSPENDEDBaltimore, Maryland, 21201, United States
-
University of Miami Miller School of Medicine-Sylvester Cancer Center
RECRUITINGMiami, Florida, 33136, United States
Contact
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.